Advertisement
Canada markets open in 2 hours 39 minutes
  • S&P/TSX

    22,107.08
    +194.56 (+0.89%)
     
  • S&P 500

    5,248.49
    +44.91 (+0.86%)
     
  • DOW

    39,760.08
    +477.75 (+1.22%)
     
  • CAD/USD

    0.7355
    -0.0017 (-0.24%)
     
  • CRUDE OIL

    82.06
    +0.71 (+0.87%)
     
  • Bitcoin CAD

    95,968.97
    +782.68 (+0.82%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,231.40
    +18.70 (+0.85%)
     
  • RUSSELL 2000

    2,114.35
    +44.19 (+2.13%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • NASDAQ futures

    18,494.50
    -9.25 (-0.05%)
     
  • VOLATILITY

    12.96
    +0.18 (+1.41%)
     
  • FTSE

    7,957.39
    +25.41 (+0.32%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • CAD/EUR

    0.6813
    +0.0008 (+0.12%)
     

Why Marijuana Stocks Plummeted in 2019

Marijuana stocks were on a tear last year, and big industry names like Canopy Growth CGC, Tilray TLRY, Cronos CRON, and Aurora Cannabis ACB were reaching new highs thanks to Canada legalizing recreational cannabis and rampant bullish sentiment.

2019, though, has sent stocks tumbling back down to Earth, with many companies losing half their value over the trailing year. What happened?

One of the biggest reasons is a supply shortage, as a lot of Canadian growers waited too long to expand their capacity. There’s also the issue of cultivation and processing application backlogs, as well as high tax rates in the U.S. and a significant delay in the launch of the derivatives market (derivatives are products like edibles, vape pods, and infused beverages. Plus, there’s the regulatory and accounting issues that have left investors cold.

It will likely take a long time before Wall Street trusts marijuana stocks again, and despite expected growing pains and being the “next big thing,” investing in marijuana stocks will continue to be a bumpy ride.

ADVERTISEMENT

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year. See their latest picks free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Tilray, Inc. (TLRY) : Free Stock Analysis Report
 
Aurora Cannabis Inc. (ACB) : Free Stock Analysis Report
 
Canopy Growth Corporation (CGC) : Free Stock Analysis Report
 
Cronos Group Inc. (CRON) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research